Scientific Sessions 2024  /  Applying Advances in Risk Prediction to PREVENT CV Disease  /  Case: managing a patient with discordant ASCVD and HF risk
Logo

American Heart Association

  130
  0

Final ID:

Case: managing a patient with discordant ASCVD and HF risk

  • Ostrominski, John  ( Brigham and Womens Hospital , Boston , Massachusetts , United States )
    • Author Disclosures:
    John Ostrominski: DO NOT have relevant financial relationships
Meeting Info:

Scientific Sessions 2024

2024

Chicago, Illinois

Session Info:

Applying Advances in Risk Prediction to PREVENT CV Disease

Monday, 11/18/2024 , 01:30PM - 02:45PM

Cardiovascular Seminar

More abstracts on this topic:
Using long term risk estimates to support CVD prevention efforts

Berry Jarett, Magnani Jared

Cardiovascular health, CKM Syndrome, and CVD Risk Prediction: Putting it all together

Lloyd-jones Donald, Ndumele Chiadi

More abstracts from these authors:
Safety and Effectiveness of Metabolic and Bariatric Procedures in Heart Failure: A Single-Center Cohort Study

Ostrominski John, Schwede Madeleine, Lodi Jenna, Jirapinyo Pichamol, Spector David, Sheu Eric, Platz Elke

Effect of Caloric Restriction on Cardiovascular-Kidney-Metabolic Health in Young Adults: Insights from the CALERIE Trial

Chang Ryan, Claggett Brian, Redman Leanne, Ravussin Eric, Apovian Caroline, Ostrominski John

You have to be authorized to contact abstract author. Please, Login
Not Available